Advocating for Impact: A Court Win for Pharmacy Residency Programs

This podcast provides members an overview of the impact of a recent federal court decision on PGY-1 residency program disallowances. We’ll cover what the ruling means for programs under audit and what comes next with CMS advocacy. 

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.